{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T20:03:30Z","timestamp":1720296210837},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,22]],"date-time":"2015-08-22T00:00:00Z","timestamp":1440201600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-1034-5","type":"journal-article","created":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T10:56:47Z","timestamp":1440154607000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the M\u0101ori and non-M\u0101ori populations in New Zealand"],"prefix":"10.1186","volume":"15","author":[{"given":"Yoon-Jung","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazel","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Simonella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold","family":"Neal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Collette","family":"Bromhead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Canfell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,22]]},"reference":[{"key":"1034_CR1","unstructured":"HPV immunisation programme. [ http:\/\/www.health.govt.nz\/our-work\/preventative-health-wellness\/immunisation\/hpv-immunisation-programme ]"},{"key":"1034_CR2","unstructured":"Changes to the National Immunisation Schedule. 17 December 2013 [ http:\/\/www.pharmac.health.nz\/news\/notification-2013-12-17-national-immunisation-schedule-changes\/ ]"},{"key":"1034_CR3","unstructured":"HPV immunisation programme: HPV Immunisation Coverage by Ethnicity, Vaccination and Eligible Birth cohort - All DHBs. [ http:\/\/www.health.govt.nz\/our-work\/preventative-health-wellness\/immunisation\/hpv-immunisation-programme ]"},{"key":"1034_CR4","unstructured":"HPV Immunisation Programme Implementation Evaluation. Volume 1: Final Report. Prepared for Ministry of Health Manat\u016b Hauora. 25 June 2012."},{"key":"1034_CR5","volume-title":"Cancer: New registrations and deaths 2010","author":"Ministry of Health","year":"2013","unstructured":"Ministry of Health. Cancer: New registrations and deaths 2010. Wellington: Ministry of Health; 2013."},{"key":"1034_CR6","volume-title":"National Cervical Screening Programme Monitoring Report Number 37","author":"M Smith","year":"2013","unstructured":"Smith M, Walker R, Canfell K. National Cervical Screening Programme Monitoring Report Number 37. 2013."},{"key":"1034_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1471-2334-13-114","volume":"13","author":"LM Simonella","year":"2013","unstructured":"Simonella LM, Lewis H, Smith M, Neal H, Bromhead C, Canfell K. Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand. BMC Infect Dis. 2013;13:114.","journal-title":"BMC Infect Dis"},{"key":"1034_CR8","unstructured":"New Zealand National Cervical Screening Programme. Bethesda 2001 New Zealand Modified:Codes, descriptors and assessment of sample adequacy for cytology laboratories. In: Ministry of Health National Screening Unit, editor. New Zealand: New Zealand National Cervical Screening Programme; 2005."},{"key":"1034_CR9","unstructured":"Ethnicity Data Protocols for the Health and Disability Sector. [ http:\/\/www.health.govt.nz\/publication\/ethnicity-data-protocols-health-and-disability-sector ]"},{"key":"1034_CR10","unstructured":"Smith M, Walker R, Clements M, Canfell K. National Cervical Screening Programme Monitoring Report Number 32. Wellington, New Zealand; 2011."},{"issue":"2","key":"1034_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/sj.bjc.6605747","volume":"103","author":"R Howell-Jones","year":"2010","unstructured":"Howell-Jones R, Bailey A, Beddows S, Sargent A, de Silva N, Wilson G, et al. Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England. Br J Cancer. 2010;103(2):209\u201316.","journal-title":"Br J Cancer"},{"issue":"1","key":"1034_CR12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.38.1.357-361.2000","volume":"38","author":"PE Gravitt","year":"2000","unstructured":"Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutl\u00e9e F, Hildesheim A, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38(1):357\u201361.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1034_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens--Part B: biological agents. Lancet Oncol. 2009;10(4):321\u20132.","journal-title":"Lancet Oncol"},{"issue":"3","key":"1034_CR14","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1158\/1055-9965.EPI-08-0951","volume":"18","author":"C Porras","year":"2009","unstructured":"Porras C, Rodr\u00edguez AC, Hildesheim A, Herrero R, Gonz\u00e1lez P, Wacholder S, et al. Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women. Cancer Epidemiol Biomarkers Prev. 2009;18(3):863\u20135.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1034_CR15","doi-asserted-by":"crossref","unstructured":"Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr. 2003(31):14\u20139.","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476"},{"issue":"10","key":"1034_CR16","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/ijc.27485","volume":"131","author":"P Guan","year":"2012","unstructured":"Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S, et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131(10):2349\u201359.","journal-title":"Int J Cancer"},{"issue":"4 Suppl","key":"1034_CR17","first-page":"S5","volume":"43","author":"JS Smith","year":"2008","unstructured":"Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health. 2008;43(4 Suppl):S5\u201325. S25.","journal-title":"J Adolesc Health"},{"issue":"12","key":"1034_CR18","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/infdis\/jis627","volume":"206","author":"S Hariri","year":"2012","unstructured":"Hariri S, Unger ER, Powell SE, Bauer HM, Bennett NM, Bloch KC, et al. Human papillomavirus genotypes in high-grade cervical lesions in the United States. J Infect Dis. 2012;206(12):1878\u201386.","journal-title":"J Infect Dis"},{"issue":"4","key":"1034_CR19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.24095\/hpcdp.32.4.01","volume":"32","author":"AA Demers","year":"2012","unstructured":"Demers AA, Shearer B, Severini A, Lotocki R, Kliewer EV, Stopera S, et al. Distribution of human papillomavirus types, cervical cancer screening history, and risk factors for infection in Manitoba. Chronic Dis Inj Can. 2012;32(4):177\u201385.","journal-title":"Chronic Dis Inj Can"},{"key":"1034_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1741-7015-9-104","volume":"9","author":"SM Garland","year":"2011","unstructured":"Garland SM, Brotherton JM, Condon JR, McIntyre PB, Stevens MP, Smith DW, et al. Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Med. 2011;9:104.","journal-title":"BMC Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1034-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-1034-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1034-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T19:23:42Z","timestamp":1653074622000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-1034-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,22]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1034"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-1034-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,22]]},"article-number":"365"}}